Sergio R. V.
- Country
- Spain
- Department
- Servicio de cirugía oral y maxilofacial
Research Overview
Data & Insights
Has run more than one trial at 0 of 7 partner sites.
Specializations
Pharmacogenetics and Acute Pain Management
Integration of pharmacogenetics to personalize analgesic therapy and reduce adverse events in surgical patients.
- CYP2D6 genotyping
- tramadol optimization
- acute postoperative pain
- precision analgesia
Focuses on precision medicine approaches for postoperative pain control.
Vascular Thromboembolism
Evaluation of adjunctive respiratory therapies for patients with intermediate‑risk embolic events.
- supplemental oxygen
- acute pulmonary embolism
- short‑term clinical outcomes
- risk‑adjusted management
Targets improvement of early recovery and complication reduction.
Oncology – Locally Advanced Colon Cancer
Assessment of multimodal treatment sequences to extend survival after curative resection.
- neoadjuvant chemotherapy
- locally advanced colon cancer
- disease‑free survival
- combined modality therapy
Seeks to define optimal peri‑operative strategies for high‑risk colorectal tumors.
Cardiovascular Risk & Statin Pharmacogenomics
Preemptive genetic screening to mitigate musculoskeletal toxicity in patients requiring intensive lipid‑lowering therapy.
- statin preemptive genotyping
- musculoskeletal adverse events
- high‑intensity statin therapy
- personalized cardiovascular prevention
Supports safer statin utilization in high‑risk populations.
Diabetic Ischemic Ulcer Management
Investigation of hyperbaric oxygen as an adjunct to standard wound care for limb‑saving outcomes.
- hyperbaric oxygen therapy
- ischemic diabetic foot ulcer
- major amputation prevention
- wound healing optimization
Aims to reduce amputation rates through enhanced tissue oxygenation.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.